Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCPT.L Regulatory News (CPT)

  • There is currently no data for CPT

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Completion of Equity Swap and Payment Acceleration

27 Jan 2014 09:24

RNS Number : 5649Y
Frontier Resources International
27 January 2014
 



For immediate release

27 January 2014

Frontier Resources International Plc

("Frontier" or the "Company")

Completion of Equity Swap and Payment Acceleration

 

The Board of Frontier (AIM Ticker: FRI), is pleased to announce that the Company's broker has today conditionally placed with institutional investors YA Global Master SPV Ltd's ("YA Global") current entire holding of 8,138,325 ordinary shares in the Company ("YA Global Placing").

On 19 June 2013 the Company had entered into an equity swap agreement with YA Global. Separately YA Global agreed to subscribe for 8,333,333 of the Company's Ordinary Shares (the "Equity Swap Shares"). Under the equity swap agreement, YA Global agreed to make 15 monthly settlement payments of £33,333 each to the Company, subject to adjustment to reflect the price of the Equity Swap Shares sold by YA Global at such time. The Company had the right at any time to accelerate the payments due under the equity swap by procuring subscribers for all the Equity Swap Shares held by YA Global: The Company has exercised this right today as the Directors believe that given the next stage in the Company's development, it would be in the Company's best interests to accelerate and terminate the equity swap agreement now.

On completion of the YA Global Placing, YA Global will make a single final payment to the Company and the equity swap agreement will then terminate. The funds will be used by the Company to provide additional funding for the Group's exploration activities.

The issued share ordinary share capital of the Company remains unchanged at 110,055,505 Ordinary Shares. The Equity Swap Shares were placed at 2.6 per Ordinary Share.

Enquiries:

Frontier Resources International Plc

Jack Keyes, Chief Executive Officer 

Tel: +1 (713) 962 0887

or

Barbara Spurrier, Finance Director

Tel: 020 3475 8108

Beaumont Cornish Limited (Nomad)

Michael Cornish / Roland Cornish

Tel: 0207 628 3396

WH Ireland Limited (Joint Broker)

James Joyce / James Bavister

Tel: Tel: 0207 220 1666

Beaufort Securities Limited (Joint Broker)

Christopher Rourke / Guy Wheatley

Tel: 020 7382 8300

Yellow Jersey PR Limited (Financial PR)

Dominic Barretto

Tel: +44(0) 7768 537 739

or

Anna Legge

Tel: +44 (0) 7747 788 221

 

A copy of this announcement is available from the Company's website www.friplc.com

 

About Frontier:

Frontier Resources International Plc, which was founded in April 2008, is focused on onshore oil and gas exploration and development in the Middle East and Southern Africa where the Company has technical knowledge and expertise. The Company currently has three exploration projects in Oman, Zambia and Namibia.

 

Frontier's immediate objectives are to continue developing its core exploration projects towards first production particularly in Oman where the Company's knowledge base is most advanced because of the proximity to producing oil and gas fields and the availability of existing seismic and well data.

 

The Company is incorporated in the United Kingdom with its registered office in London. It also maintains a technical and commercial office in the United States in Houston, Texas. Additionally, to support its regional operations in Southern Africa and the Middle East, offices are maintained in Namibia, Zambia and Oman.

 

The Company's shares were admitted to AIM of the London Stock Exchange on 5 July 2013.

 

ENDS

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGUUPGUPCUBM
Date   Source Headline
27th Sep 20187:00 amRNSInterim Results
21st Sep 20189:47 amRNSHolding(s) in Company
28th Aug 20187:00 amRNSHolding(s) in Company
13th Aug 201812:55 pmRNSHolding(s) in Company
13th Aug 20187:00 amRNSHolding(s) in Company
9th Aug 201812:15 pmRNSHolding(s) in Company
2nd Aug 20187:00 amRNSOversubscribed placing raises £2,000,000
17th Jul 20187:00 amRNSBoard Changes
14th Jun 201810:22 amRNSResult of AGM
22nd May 20185:13 pmRNSNotice of AGM
1st May 20187:00 amRNSFinal Results
26th Apr 201810:00 amRNSLogistics deal with major Chinese player SinoPharm
9th Apr 20188:25 amRNSConcepta manufacturing site achieves certification
29th Mar 20187:00 amRNSConcepta pre-launch myLotus in the UK
8th Mar 20187:00 amRNSmyLotus obtains approval to commence trial in UK
20th Feb 20187:00 amRNSLaunch of myLotus app in China
16th Feb 20187:00 amRNSTwo Senior Appointments and Grant of Options
15th Feb 20187:00 amRNSConcepta signs marketing contract in China
2nd Feb 20184:17 pmRNSHolding(s) in Company
29th Jan 20187:00 amRNSResults of Chinese hospital evaluations of myLotus
2nd Jan 201812:52 pmRNSChange of Broker
22nd Dec 201711:30 amRNSTrading update
14th Dec 20177:00 amRNSAssembly held in Shanghai to showcase myLotus
30th Nov 20173:05 pmRNSDirector/PDMR Shareholding
29th Nov 20179:02 amRNSHolding(s) in Company
13th Nov 20177:02 amRNSAppointment of Joint Corporate Broker
13th Nov 20177:01 amRNSOversubscribed equity fundraising of £2,000,000
13th Nov 20177:00 amRNSSales Order
6th Nov 201712:53 pmRNSTrading and Order Update
16th Oct 20177:00 amRNSmyLotus Fertility Product - China Update
19th Sep 20177:00 amRNSInterim Results
23rd Aug 201712:00 pmRNSCorporate Update
26th Jun 20177:00 amRNSDirector Shareholding
14th Jun 201712:00 pmRNSResult of AGM
13th Jun 20177:00 amRNSFirst Sales Order China and Trading Update
24th May 20174:58 pmRNSNotice of AGM
10th May 20177:00 amRNSFirst distributor agreement in China
26th Apr 20177:00 amRNSFinal Results
29th Mar 201710:00 amRNSUK Investor Show 2017
28th Mar 20177:00 amRNSDirectorate Changes
14th Feb 20171:45 pmRNSChange of Registered Office
7th Feb 20177:00 amRNSConcepta signs agreement with Selective Antibodies
9th Jan 20177:00 amRNSConcepta achieves ISO13485 accreditation
8th Dec 20167:00 amRNSAppointment China Country Manager
8th Nov 20167:09 amRNSNew manufacturing facility in Doncaster
10th Oct 20163:53 pmRNSIssue of Equity
26th Sep 20167:00 amRNSChinese Manufacturing Agreement Signed
21st Sep 20167:00 amRNSNew Laboratory Opening
18th Aug 20167:00 amRNSInterim Results
27th Jul 20164:11 pmRNSTR-1: Notification of major interest in shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.